Medivir: Birinapant ASCO 2019 presentation

Research Note

2019-06-04

15:46

The oral presentation of the phase I birinapant combination trial at ASCO 2019 provided some new encouraging data. We look forward to further data later this year and reiterate our base case fair value of SEK 29.

KP

Klas Palin

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.